|
|
 |
|
Viewing report
|
|
|
|
Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2012, Pages: 44
Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review
Summary
Affymetrix, Inc. (Affymetrix) is a medical equipment company engaged in the development, production, sales and service of consumables and equipment systems for genetic analysis in the life sciences and clinical healthcare markets. It offers products principally for two applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument systems, namely, GeneChip, GeneTitan and GeneAtlas that include instruments, consumables and software. The company’s platform is based on its GeneChip system and related microarray technology, which is used to acquire, analyze and manage complex genetic information. Affymetrix's products are widely used by pharmaceutical, biotechnology, agrichemical, diagnostic and consumer product companies, as well as academic, government and other non-profit research institutes. Its operations are spread across the US, Europe, Japan and several other regions. Affymetrix is headquartered in California, the US.
The company aims to expand geographically and improve its operational efficiencies. Inline with this strategy the company recently entered into a global distribution agreement with Almac Group Ltd.
Affymetrix, Inc. Key Recent Developments
Feb 23, 2012: Affymetrix Announces Immediate Shipment Of New Axiom Exome Genotyping Arrays
Feb 08, 2012: Affymetrix Reports Revenue Of $267.5m In 2011
Nov 02, 2011: Affymetrix Reports Revenues Of $64m In Q3 2011
Oct 06, 2011: Affymetrix Launches 18 New Microarrays For Gene Expression Analysis Of Model And Applied Research Organisms
Aug 19, 2011: Affymetrix Announces Federal Court Affirms Dismissal Of Illumina Patent Infringement Lawsuits
This comprehensive SWOT profile of Affymetrix, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Affymetrix, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
Affymetrix, Inc.: Company Profile and SWOT Analysis
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Alliance Healthcare Services, Inc. (AIQ) - Financial and Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
Syneron Medical Ltd. (ELOS) - Financial and Strategic SWOT Analysis Review
Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review
|
|
|
|
